StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

IRDBullishAnalyst Target Updateanalyst
High materiality7/10

Opus Genetics price target raised to $16 from $13 at Chardan

Sep 9, 2026, 3:31 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

bullish

AI summary

What happened, with direct paths to the underlying reporting

Chardan raises IRD target to $16; current price around $5.67; priceChangeSinceSignal +3.53 indicates momentum.

  • Chardan raises IRD target to $16; price now $5.67.

Key facts

  1. 01

    Target: $16

  2. 02

    Posted price: $5.67

  3. 03

    Analyst firm: Chardan Capital

  4. 04

    Analyst: Andreas Argyrides

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.